Cargando…

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

BACKGROUND: mRNA coronavirus disease 2019 (COVID-19) vaccines are safe and effective, but increasing reports of breakthrough infections highlight the need to vigilantly monitor and compare the effectiveness of these vaccines. METHODS: We retrospectively compared protection against symptomatic infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puranik, Arjun, Lenehan, Patrick J., Silvert, Eli, Niesen, Michiel J.M., Corchado-Garcia, Juan, O’Horo, John C., Virk, Abinash, Swift, Melanie D., Gordon, Joel E., Speicher, Leigh Lewis, Geyer, Holly L., Kremers, Walter, Halamka, John, Badley, Andrew D., Venkatakrishnan, A.J., Soundararajan, Venky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Clinical Advances
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664708/ https://www.ncbi.nlm.nih.gov/pubmed/34927113 http://dx.doi.org/10.1016/j.medj.2021.12.002

Ejemplares similares

Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
por: Niesen, Michiel J M, et al.
Publicado: (2022)

Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021)

Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021)

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records
por: Niesen, Michiel J. M., et al.
Publicado: (2022)

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
por: Pawlowski, Colin, et al.
Publicado: (2022)

Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
por: Pawlowski, Colin, et al.
Publicado: (2021)

Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
por: Lenehan, Patrick J., et al.
Publicado: (2021)

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
por: Corchado-Garcia, Juan, et al.
Publicado: (2021)

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
por: McMurry, Reid, et al.
Publicado: (2021)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021)

Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
por: Venkatakrishnan, A. J., et al.
Publicado: (2023)

Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)

Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
por: Awasthi, Samir, et al.
Publicado: (2021)

Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
por: Pawlowski, Colin, et al.
Publicado: (2021)

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

On the Origins of Omicron’s Unique Spike Gene Insertion
por: Venkatakrishnan, A. J., et al.
Publicado: (2022)

Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
por: Anand, Praveen, et al.
Publicado: (2022)

Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
por: Pawlowski, Colin, et al.
Publicado: (2020)

Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
por: Ghosh, Pritha, et al.
Publicado: (2022)

Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
por: Romero-Brufau, Santiago, et al.
Publicado: (2021)

Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
por: Niesen, Michiel J M, et al.
Publicado: (2022)

SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
por: Anand, Praveen, et al.
Publicado: (2020)

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
por: Wagner, Tyler, et al.
Publicado: (2020)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2
por: Venkatakrishnan, A. J., et al.
Publicado: (2020)

Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry
por: Kirkup, Christian, et al.
Publicado: (2021)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
por: Suratekar, Rohit, et al.
Publicado: (2022)

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
por: Razonable, Raymund R., et al.
Publicado: (2021)

1243. Comparative Analysis of Antimicrobial-related Adverse Events in the Outpatient Treatment of Staphylococcal Infections
por: Smith, Bradley, et al.
Publicado: (2018)

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
por: Ballman, Madison, et al.
Publicado: (2021)

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
por: Dickerman, Barbra A., et al.
Publicado: (2021)

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
por: Thompson, Mark G., et al.
Publicado: (2021)

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern
por: Murugadoss, Karthik, et al.
Publicado: (2022)

BNT162b2, mRNA-1273, et EMA : une procédure qui roule
por: Dalmat, Yann-Mickael
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ppv2n0655ul277k6s36ga1312